TURTLE CAMERON (Chief Executive Officer) reported 1 transaction at SPYRE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/27/2023ACC: 0000950170-23-066131
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+1.08M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.10M acquired · 18.09K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+723.44K
Price / share
—
Trade value
—
% of position
3136.3%
11/24/2023
23.07K→746.51K
Total
Net shares
+723.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2023 | C · Conversion | +723.44K | — | — | 3136.3% | 23.07K | 746.51K |
| Total | +723.44K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
374K shares
Shares
+374K
Strike price
10.39
Held after
374K
Exercisable
—
11/22/2023
Series A Preferred Stock
Direct
Converts to
Common Stock
723.44K shares
Shares
−18.09K
Strike price
Held after
0.00
Exercisable
—
11/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock374K shares | 11/22/2023 | A · Award | +374K | 10.39 | — | 374K |
| Series A Preferred Stock Direct | Common Stock723.44K shares | 11/24/2023 | C · Conversion | −18.09K | — | 0.00 |